OmniAb OABI
NASDAQ OABI
$4.99 +0.03 (+0.60%)
At close: Oct 1, 2026 · 4:00 PM EDT

OmniAb (OABI) Liabilities and Shareholders Equity (2021 - 2026)

Updated

OmniAb (OABI) posted Liabilities and Shareholders Equity of $290.26 million for Q2 2026, down 1.8% from $295.67 million a year earlier and down 1.2% from the prior quarter.

Analysis

OmniAb (OABI) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends

At the end of FY2025, OmniAb's Liabilities and Shareholders Equity came in at $300.91 million, down 7.6% from FY2024.

  • Annual Liabilities and Shareholders Equity has declined for three consecutive years, with a four-year compound annual growth rate of -0.3% (FY2021 to FY2025).
  • In prior years, OmniAb's Liabilities and Shareholders Equity was $325.56 million in FY2024 (-13.2%), $375.23 million in FY2023 (-10.9%), $421.21 million in FY2022 (+38.3%) and $304.47 million in FY2021.
  • The Q2 2026 figure stands as the lowest quarterly Liabilities and Shareholders Equity since Q3 2022.
  • On a year-over-year basis, Liabilities and Shareholders Equity has declined in each of the last 11 quarters, with an average decline of 9.3% over the last eight quarters.
  • The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was Q1 2023, with growth of 74.4%; the weakest was Q2 2024, with a decline of 16.8%.
  • According to Business Quant data, Liabilities and Shareholders Equity for the three prior quarters was $293.65 million (Q1 2026), $300.91 million (Q4 2025) and $309.69 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 OmniAb 721.14 Mn 506.54 Mn 12.81 Mn 290.26 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 290.26 Mn
Mar 31, 2026 293.65 Mn
Dec 31, 2025 300.91 Mn
Sep 30, 2025 309.69 Mn
Jun 30, 2025 295.67 Mn
Mar 31, 2025 306.18 Mn
Dec 31, 2024 325.56 Mn
Sep 30, 2024 331.55 Mn
Jun 30, 2024 337.26 Mn
Mar 31, 2024 352.56 Mn
Dec 31, 2023 375.23 Mn
Sep 30, 2023 391.71 Mn
Jun 30, 2023 405.24 Mn
Mar 31, 2023 413.04 Mn
Dec 31, 2022 421.21 Mn
Sep 30, 2022 237.61 Mn
Jun 30, 2022 236.79 Mn
Mar 31, 2022 236.90 Mn
Dec 31, 2021 304.47 Mn
Sep 30, 2021 236.99 Mn
API Access

OmniAb Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=OABI&period=max&api_key=YOUR_API_KEY